The University of Nebraska Medical Center (UNMC) was awarded a $183,220 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research titled "TARGETING THE CCL17/CCR4 AXIS TO ERADICATE LUNG CANCER BRAIN METASTASIS". The grant, which has a performance period from February 1, 2025 to January 31, 2026, will support UNMC's investigative efforts to develop new treatments for addressing lung cancer metastasis to the brain. The Military Medical Research and Development program provides funding for a wide range of biomedical research initiatives aimed at improving health outcomes for military service members, veterans, and the general public. UNMC, as a leading institution in health sciences education, innovative research, and patient care, has a history of successfully securing and executing federal grants across various medical and public health domains.
Generated 3/4/25, 6:18 AM